- Alison Tonks, associate editor (atonks@bmj.com)
Sentinel node biopsy improves outcome in people with medium thickness melanomas
Sentinel node biopsy should become the standard of care for people with medium thickness melanoma, according to an editorial. A large trial (pp 1307-17) has shown that sentinel node biopsy, coupled with immediate lymphadenectomy if positive, helps control regional recurrence for everyone, and improves survival among patients with nodal metasatases.
Credit: N ENGL J MED
Patients who had the biopsy had longer disease-free survival over five years than patients who were observed and offered lymphadenectomy only when their diseased nodes became obvious clinically (78% v 73%; hazard ratio for death 0.74; 95% CI 0.59 to 0.93). Sentinel node biopsy didn't prolong overall survival, but among the 16% of patients with nodal metastases, those who had the biopsy followed by immediate surgery survived significantly longer than those who had to wait for their surgery until their lymph nodes got big enough to palpate (72% five years survival v 52%; hazard ratio for death, 0.51, 0.32 to 0.81). During a median wait of 16 months, their tumours progressed and the mean number of malignant lymph nodes increased from 1.4 to 3.3 (P < 0.001).
Credit: JAMA
US emergency medical services are in crisis
As the threat of terrorism becomes more real in the US, the emergency medical services required to deal with its aftermath are in serious decline, writes a professor of emergency medicine from Atlanta. His department and many others are overflowing, demoralised, and stretched beyond their capacity to cope with any kind of mass casualty event. Patients are being “boarded” in corridors and examination rooms waiting for beds, and overcrowded hospitals are increasingly turning away ambulances—at a rate of about one every minute.
He blames the “upside down world” of federal funding for these well documented and worsening problems. Between 2000 and 2006 the government increased spending on bioterrorism “preparedness” from $237m (£126m, €187m) to $9.6bn, …
Sign in
Personal subscribers, sign in here:
Article access
Article access for 1 day
Purchase this article for £20 $30 €32*
The PDF version can be downloaded as your personal record
CiteULike
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter
Stumbleupon
Rapid responses
Latest Responses
The decline in the breast cancer incidence is 1.2% and it is not significant.
Published 10 February 2012
'twas ever thus
Published 10 February 2012
The value of historic human remains
Published 10 February 2012
In Praise of British Literature
Published 10 February 2012
Is real shared decision making possible?
Published 10 February 2012
Most responses
Does anyone understand the government’s plan for the NHS? (17 responses)
Published 17 Jan 2012
Bad medicine: medical nutrition (15 responses)
Published 18 Jan 2012
Shared decision making: really putting patients at the centre of healthcare (7 responses)
Published 27 Jan 2012
Why legislation is necessary for my health reforms (7 responses)
Published 1 Feb 2012
Search for evidence goes on (5 responses)
Published 17 Jan 2012